Haustus Bio Tech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.92 Cr
- Satisfied Charges ₹ 1.36 Cr
About Haustus Bio Tech
Haustus Bio Tech Private Limited (HBTPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 April 2005 and has a history of 19 years and nine months. Its registered office is in Himachal Pradesh, Himachal Pradesh.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹11.92 Cr. The company has closed loans amounting to ₹1.36 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vinod Sharma and Rishi Sharma serve as directors at the Company.
Company Details
- Location Himachal Pradesh, Himachal Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230HP2005PTC028327
- Company No.
028327
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
What products or services does Haustus Bio Tech Private Limited offer?
Haustus Bio Tech Private Limited offers a wide range of products and services, including Aceclofenac Tablet, Aceclofenac Paracetamol Serratiopeptidase Tablet, Pharma Franchise, PCD Pharma Franchise, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Antibacterial Drugs, Ofloxacin Tablet IP, Pharmaceutical Distributors, Mineral Supplement.
Who are the key members and board of directors at Haustus Bio Tech?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vinod Sharma ![]() | Director | 11-Mar-2012 | Current |
Rishi Sharma ![]() | Director | 26-Mar-2011 | Current |
Financial Performance of Haustus Bio Tech.
Haustus Bio Tech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Haustus Bio Tech?
Unlock access to Haustus Bio Tech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)
₹119.19 M
₹13.60 M
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 6.23 Cr
- Hdfc Bank Limited : 4.61 Cr
- Sidbi : 1.00 Cr
- Others : 0.09 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
26 Sep 2023 | Hdfc Bank Limited | ₹1.20 M | Open |
15 Nov 2022 | Hdfc Bank Limited | ₹3.53 Cr | Open |
22 Mar 2022 | Sidbi | ₹1.00 Cr | Open |
02 Feb 2022 | Others | ₹0.39 M | Open |
17 Nov 2017 | Others | ₹0.47 M | Open |
How Many Employees Work at Haustus Bio Tech?
Haustus Bio Tech has a workforce of 61 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Haustus Bio Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Haustus Bio Tech's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.